Search Results
Introduction: entity encounters and the psychedelic mystical experience The ‘psychedelic experience’ is a temporary altered state of consciousness induced by a psychedelic compound. While psychedelic altered states are highly specific to particular
renewed interest ( Carhart-Harris & Goodwin, 2017 ). Here, we examine first social factors shaping the current landscape of psychedelic treatment research. Early psychedelic research focused on their efficacy from a medical perspective (see Garcia
Introduction Increasing evidence suggests that ingestion or administration of classic psychedelics such as psilocybin or LSD is sometimes associated with improvements in well-being or mental health in both clinical populations ( Andersen, Carhart
perform as well for those with co-morbid problems (See Mitchell et al., 2023 ). These drawbacks inspired work on a number of alternative approaches including psychedelic-assisted treatment (PAT). The relevance of psychedelics Despite these optimistic
Introduction Psychedelic substances such as psilocybin, LSD and DMT have been researched for their potential therapeutic effectiveness in treatment of various mental health conditions since the early 1940's. However, due to stricter political
Introduction Psychedelic drugs are found in nature in multiple species of plants, fungi and animals ( Rätsch, 2005 ). The use of certain compounds (i.e., mescaline, psilocybin, N,N-dimethyltryptamine [DMT]) has been
majority of psychedelic studies was conducted in the 1960s and 1970s, and showed a great deal of promise for psychedelics as therapeutic agents ( Dutta, 2012 ; Gasser, Kirchener, & Passie, 2014 ; Reiche et al., 2018 ). Recently, there have been four main
Introduction “ We can’t start history of psychedelics in the ‘60s in the Americas; that needs to stop. We [indigenous people] used this medicine before Jesus Christ walked this Earth
Introduction The articles in this Special Issue on “ Psychedelics in History and World Religions ” offer compelling documentation of entheogen use in prehistorical and historical societies. Winkelman’s review of the literature
Introduction: pharmacovigilance beyond the individual level? In December 2023 the Multidisciplinary Association for Psychedelic Studies submitted a new drug application to the Food & Drug Administration for the use of MDMA in the treatment of post
